French biopharmaceutical company Ipsen (IPSEY) said it has initiated a share buy-back program to cover its free employee share-allocation plan and employee share plan.
The company has appointed an investment-services provider to purchase an aggregate number of Ipsen shares up to 400,000, or about 0.47% of the share capital, over a maximum period of six months.
The program is made pursuant to the authorization granted by the Company's Annual General Meeting, held on 28 May 2024.
For comments and feedback: editorial@rttnews.com